00092-0/asset/9cb4d176-26e3-4508-8aa1-ecdb4e971f8d/main.assets/gr3_lrg.jpg)
retatrutide case study Effects of on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial Weight loss with retatrutide1, tirazepatide2,
Description
Long-Term Results: Six Months and Beyond Clinical trials demonstrate that sustained use of GLP-1 medications over twelve to eighteen months can produce average weight loss of fifteen to twenty percent of starting body weight
However, evidence is insufficient to estimate recurrence risk, and decisions regarding continuation or re-initiation of therapy should be individualized
Of course, Williams still plays tennis
Ann Clin Lab Sci 2015;45:287291
[PubMed: 6990758] 72
Its meant to have low side effects, low costs, and help people ease into using the medication
